What Happened?
Cambridge, MA-based Sigilon Resigned Martha Rook as Chief Technical Operations Officer
About the Company
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
About the Person
Martha Rook is Chief Technical Operations Officer at Insitro. Previously, Martha held various senior IT leadership roles in the industry.
Info Source
News
Short Profile